{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T06:40:40Z","timestamp":1780468840627,"version":"3.54.1"},"reference-count":229,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1016\/j.jaad.2012.11.002","type":"journal-article","created":{"date-parts":[[2013,2,28]],"date-time":"2013-02-28T14:50:33Z","timestamp":1362063033000},"page":"834-853","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Autoinflammation: From monogenic syndromes to common skin diseases"],"prefix":"10.1016","volume":"68","author":[{"given":"Tien V.","family":"Nguyen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward W.","family":"Cowen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kieron S.","family":"Leslie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2012.11.002_bib1","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.coi.2008.01.003","article-title":"NLR, the nucleotide-binding domain leucine-rich repeat containing gene family","volume":"20","author":"Ye","year":"2008","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.jaad.2012.11.002_bib2","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.immuni.2008.02.005","article-title":"The NLR gene family: a standard nomenclature","volume":"28","author":"Ting","year":"2008","journal-title":"Immunity"},{"key":"10.1016\/j.jaad.2012.11.002_bib3","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.cell.2010.01.040","article-title":"The inflammasomes","volume":"140","author":"Schroder","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.jaad.2012.11.002_bib4","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.cell.2007.12.040","article-title":"Active caspase-1 is a regulator of unconventional protein secretion","volume":"132","author":"Keller","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.jaad.2012.11.002_bib5","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1007\/s11882-008-0047-1","article-title":"The spectrum of monogenic autoinflammatory syndromes: understanding disease mechanisms and use of targeted therapies","volume":"8","author":"Glaser","year":"2008","journal-title":"Curr Allergy Asthma Rep"},{"key":"10.1016\/j.jaad.2012.11.002_bib6","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.4049\/jimmunol.139.6.1902","article-title":"Interleukin 1 induces interleukin\u00a01, I: induction of circulating interleukin 1 in rabbits in\u00a0vivo and in human mononuclear cells in\u00a0vitro","volume":"139","author":"Dinarello","year":"1987","journal-title":"J Immunol"},{"key":"10.1016\/j.jaad.2012.11.002_bib7","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1084\/jem.20082481","article-title":"In\u00a0vivo regulation of interleukin 1beta in patients with cryopyrin-associated periodic syndromes","volume":"206","author":"Lachmann","year":"2009","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaad.2012.11.002_bib8","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/nature09663","article-title":"A role for mitochondria in NLRP3 inflammasome activation","volume":"469","author":"Zhou","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.jaad.2012.11.002_bib9","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1159\/000334247","article-title":"Nucleotide-binding oligomerization domain-like receptors and inflammasomes in the pathogenesis of non-microbial inflammation and diseases","volume":"4","author":"Mason","year":"2012","journal-title":"J Innate Immun"},{"key":"10.1016\/j.jaad.2012.11.002_bib10","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1001\/archderm.1974.01630090020005","article-title":"Familial cold urticaria: clinical findings","volume":"110","author":"Doeglas","year":"1974","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2012.11.002_bib11","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1185\/03007990802081543","article-title":"Familial cold auto-inflammatory syndrome (FCAS): characterization of symptomatology and impact on patients' lives","volume":"24","author":"Stych","year":"2008","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.jaad.2012.11.002_bib12","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s11882-010-0160-9","article-title":"Cryopyrin-associated periodic syndrome: an update on diagnosis and treatment response","volume":"11","author":"Yu","year":"2011","journal-title":"Curr Allergy Asthma Rep"},{"key":"10.1016\/j.jaad.2012.11.002_bib13","doi-asserted-by":"crossref","first-page":"213","DOI":"10.3109\/s10165-009-0271-0","article-title":"Cryopyrin-associated periodic syndromes: background and therapeutics","volume":"20","author":"Kubota","year":"2010","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.jaad.2012.11.002_bib14","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1001\/archderm.142.12.1591","article-title":"Phenotype, genotype, and sustained response to anakinra in 22 patients with autoinflammatory disease associated with CIAS-1\/NALP3 mutations","volume":"142","author":"Leslie","year":"2006","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2012.11.002_bib15","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/j.1469-8749.2009.03336.x","article-title":"Neurological manifestations of the Mendelian-inherited autoinflammatory syndromes","volume":"51","author":"Montealegre Sanchez","year":"2009","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.jaad.2012.11.002_bib16","doi-asserted-by":"crossref","first-page":"21924","DOI":"10.1074\/jbc.M401178200","article-title":"Cryopyrin-induced interleukin 1beta secretion in monocytic cells: enhanced activity of disease-associated mutants and requirement for ASC","volume":"279","author":"Dowds","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jaad.2012.11.002_bib17","doi-asserted-by":"crossref","first-page":"3340","DOI":"10.1002\/art.10688","article-title":"De novo CIAS1 mutations, cytokine activation, and evidence for genetic heterogeneity in patients with neonatal-onset multisystem inflammatory disease (NOMID): a new member of the expanding family of pyrin-associated autoinflammatory diseases","volume":"46","author":"Aksentijevich","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaad.2012.11.002_bib18","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/ng756","article-title":"Mutation of a new gene encoding a putative pyrin-like protein causes familial cold autoinflammatory syndrome and Muckle-Wells syndrome","volume":"29","author":"Hoffman","year":"2001","journal-title":"Nat Genet"},{"key":"10.1016\/j.jaad.2012.11.002_bib19","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1086\/341357","article-title":"Chronic infantile neurological cutaneous and articular syndrome is caused by mutations in CIAS1, a gene highly expressed in polymorphonuclear cells and chondrocytes","volume":"71","author":"Feldmann","year":"2002","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.jaad.2012.11.002_bib20","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S1074-7613(04)00046-9","article-title":"NALP3 forms an IL-1beta-processing inflammasome with increased activity in Muckle-Wells autoinflammatory disorder","volume":"20","author":"Agostini","year":"2004","journal-title":"Immunity"},{"key":"10.1016\/j.jaad.2012.11.002_bib21","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1002\/art.20033","article-title":"Spectrum of clinical features in Muckle-Wells syndrome and response to anakinra","volume":"50","author":"Hawkins","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaad.2012.11.002_bib22","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1093\/rheumatology\/keh652","article-title":"Positive clinical and biochemical responses to anakinra in a 3-yr-old patient with cryopyrin-associated periodic syndrome (CAPS)","volume":"44","author":"Ramos","year":"2005","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jaad.2012.11.002_bib23","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1002\/ajmg.a.31148","article-title":"Neonatal-onset multisystem inflammatory disease (NOMID) due to a novel S331R mutation of the CIAS1 gene and response to interleukin-1 receptor antagonist treatment","volume":"140","author":"Boschan","year":"2006","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.jaad.2012.11.002_bib24","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1056\/NEJMoa055137","article-title":"Neonatal-onset multisystem inflammatory disease responsive to interleukin-1beta inhibition","volume":"355","author":"Goldbach-Mansky","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2012.11.002_bib25","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1002\/art.25057","article-title":"Long-term efficacy of the interleukin-1 receptor antagonist anakinra in ten patients with neonatal-onset multisystem inflammatory disease\/chronic infantile neurologic, cutaneous, articular syndrome","volume":"62","author":"Neven","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaad.2012.11.002_bib26","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/nm811","article-title":"Cytokine traps: multi-component, high-affinity blockers of cytokine action","volume":"9","author":"Economides","year":"2003","journal-title":"Nat Med"},{"key":"10.1016\/j.jaad.2012.11.002_bib27","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1002\/art.23620","article-title":"A pilot study to evaluate the safety and efficacy of the long-acting interleukin-1 inhibitor rilonacept (interleukin-1 Trap) in patients with familial cold autoinflammatory syndrome","volume":"58","author":"Goldbach-Mansky","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaad.2012.11.002_bib28","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1002\/art.23687","article-title":"Efficacy and safety of rilonacept (interleukin-1 Trap) in patients with cryopyrin-associated periodic syndromes: results from two sequential placebo-controlled studies","volume":"58","author":"Hoffman","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaad.2012.11.002_bib29","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1056\/NEJMoa0810787","article-title":"Use of canakinumab in the cryopyrin-associated periodic syndrome","volume":"360","author":"Lachmann","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2012.11.002_bib30","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S0025-6196(11)63565-9","article-title":"A new autosomal dominant disorder of pyogenic sterile arthritis, pyoderma gangrenosum, and acne: PAPA syndrome","volume":"72","author":"Lindor","year":"1997","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jaad.2012.11.002_bib31","doi-asserted-by":"crossref","first-page":"13501","DOI":"10.1073\/pnas.2135380100","article-title":"Pyrin binds the PSTPIP1\/CD2BP1 protein, defining familial Mediterranean fever and PAPA syndrome as disorders in the same pathway","volume":"100","author":"Shoham","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaad.2012.11.002_bib32","doi-asserted-by":"crossref","first-page":"519","DOI":"10.2174\/138920210793175921","article-title":"Clinical, molecular, and genetic characteristics of PAPA syndrome: a review","volume":"11","author":"Smith","year":"2010","journal-title":"Curr Genomics"},{"key":"10.1016\/j.jaad.2012.11.002_bib33","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1097\/00124743-200210000-00009","article-title":"Pyogenic arthritis, pyoderma gangrenosum, and acne syndrome (PAPA syndrome) associated with hypogammaglobulinemia and elevated serum tumor necrosis factor-alpha levels","volume":"8","author":"Edrees","year":"2002","journal-title":"J Clin Rheumatol"},{"key":"10.1016\/j.jaad.2012.11.002_bib34","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1542\/peds.56.4.570","article-title":"\u201cStreaking leukocyte factor,\u201d arthritis, and pyoderma gangrenosum","volume":"56","author":"Jacobs","year":"1975","journal-title":"Pediatrics"},{"key":"10.1016\/j.jaad.2012.11.002_bib35","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1111\/j.1365-2133.2009.09404.x","article-title":"Targeted treatment of pyoderma gangrenosum in PAPA (pyogenic arthritis, pyoderma gangrenosum and acne) syndrome with the recombinant human interleukin-1 receptor antagonist anakinra","volume":"161","author":"Brenner","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2012.11.002_bib36","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1111\/j.1525-1470.2005.22320.x","article-title":"Dramatic improvement of pyoderma gangrenosum with infliximab in a patient with PAPA syndrome","volume":"22","author":"Stichweh","year":"2005","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.jaad.2012.11.002_bib37","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.jpeds.2004.08.001","article-title":"Abnormal production of tumor necrosis factor (TNF)\u2013alpha and clinical efficacy of the TNF inhibitor etanercept in a patient with PAPA syndrome","volume":"145","author":"Cortis","year":"2004","journal-title":"J Pediatr"},{"key":"10.1016\/j.jaad.2012.11.002_bib38","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/RHU.0b013e3181e969b9","article-title":"Clinical efficacy of etanercept for treatment of PAPA syndrome","volume":"16","author":"Tofteland","year":"2010","journal-title":"J Clin Rheumatol"},{"key":"10.1016\/j.jaad.2012.11.002_bib39","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1136\/ard.2009.126185","article-title":"Variable expression and treatment of PAPA syndrome","volume":"70","author":"Schellevis","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaad.2012.11.002_bib40","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0022-3476(05)81080-7","article-title":"Autosomal dominant granulomatous arthritis, uveitis, skin rash, and synovial cysts","volume":"117","author":"Pastores","year":"1990","journal-title":"J Pediatr"},{"key":"10.1016\/j.jaad.2012.11.002_bib41","first-page":"842","article-title":"Analysis of a large kindred with Blau syndrome for HLA, autoimmunity, and sarcoidosis","volume":"147","author":"Raphael","year":"1993","journal-title":"Am J Dis Child"},{"key":"10.1016\/j.jaad.2012.11.002_bib42","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/j.ajo.2006.06.064","article-title":"Blau syndrome associated with a CARD15\/NOD2 mutation","volume":"142","author":"Snyers","year":"2006","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jaad.2012.11.002_bib43","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1016\/S0161-6420(03)00717-6","article-title":"Ocular\u00a0manifestations in Blau syndrome associated with a CARD15\/Nod2 mutation","volume":"110","author":"Kurokawa","year":"2003","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jaad.2012.11.002_bib44","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1067\/S0190-9622(02)61772-4","article-title":"Blau syndrome: a new kindred","volume":"49","author":"Alonso","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2012.11.002_bib45","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1001\/archderm.143.3.386","article-title":"Widespread granulomatous dermatitis of infancy: an early sign of Blau syndrome","volume":"143","author":"Schaffer","year":"2007","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2012.11.002_bib46","first-page":"635","article-title":"Leg ulcers: a new symptom of Blau syndrome?","volume":"18","author":"Dhondt","year":"2008","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.jaad.2012.11.002_bib47","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1525-1470.2009.01060.x","article-title":"Sporadic Blau syndrome with onset of widespread granulomatous dermatitis in the newborn period","volume":"27","author":"Stoevesandt","year":"2010","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.jaad.2012.11.002_bib48","doi-asserted-by":"crossref","first-page":"3041","DOI":"10.1002\/art.10618","article-title":"CARD15 mutations in familial granulomatosis syndromes: a study of the original Blau syndrome kindred and other families with large-vessel arteritis and cranial neuropathy","volume":"46","author":"Wang","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaad.2012.11.002_bib49","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/S0022-3476(98)70286-0","article-title":"Familial granulomatous arthritis (Blau syndrome) with granulomatous renal lesions","volume":"133","author":"Ting","year":"1998","journal-title":"J Pediatr"},{"key":"10.1016\/j.jaad.2012.11.002_bib50","first-page":"396","article-title":"Liver involvement in familial granulomatous arthritis (Blau syndrome)","volume":"23","author":"Saini","year":"1996","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jaad.2012.11.002_bib51","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1002\/art.22509","article-title":"Interstitial pneumonitis in Blau syndrome with documented mutation in CARD15","volume":"56","author":"Becker","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaad.2012.11.002_bib52","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.7326\/0003-4819-73-6-1038_2","article-title":"Prognosis of sarcoidosis","volume":"73","author":"Israel","year":"1970","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jaad.2012.11.002_bib53","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/ng720","article-title":"CARD15 mutations in Blau syndrome","volume":"29","author":"Miceli-Richard","year":"2001","journal-title":"Nat Genet"},{"key":"10.1016\/j.jaad.2012.11.002_bib54","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1053\/gast.2003.50153","article-title":"CARD15\/NOD2 functions as an antibacterial factor in human intestinal epithelial cells","volume":"124","author":"Hisamatsu","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaad.2012.11.002_bib55","doi-asserted-by":"crossref","first-page":"4812","DOI":"10.1074\/jbc.M008072200","article-title":"Nod2, a Nod1\/Apaf-1 family member that is restricted to monocytes and activates NF-kappaB","volume":"276","author":"Ogura","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jaad.2012.11.002_bib56","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1002\/art.24222","article-title":"The NOD2 defect in Blau syndrome does not result in excess interleukin-1 activity","volume":"60","author":"Martin","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaad.2012.11.002_bib57","doi-asserted-by":"crossref","first-page":"3805","DOI":"10.1002\/art.22966","article-title":"NOD2 gene-associated pediatric granulomatous arthritis: clinical diversity, novel and recurrent mutations, and evidence of clinical improvement with interleukin-1 blockade in a Spanish cohort","volume":"56","author":"Arostegui","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaad.2012.11.002_bib58","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/art.25035","article-title":"Thalidomide dramatically improves the symptoms of early-onset sarcoidosis\/Blau syndrome: its possible action and mechanism","volume":"62","author":"Yasui","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaad.2012.11.002_bib59","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1111\/j.1600-0463.2006.apm_522.x","article-title":"Favorable effect of TNF-alpha inhibitor (infliximab) on Blau syndrome in monozygotic twins with a de novo CARD15 mutation","volume":"114","author":"Milman","year":"2006","journal-title":"APMIS"},{"key":"10.1016\/j.jaad.2012.11.002_bib60","doi-asserted-by":"crossref","first-page":"26","DOI":"10.4161\/derm.2.1.12387","article-title":"Skin manifestations in tumor necrosis factor receptor-associated periodic syndrome (TRAPS)","volume":"2","author":"Schmaltz","year":"2010","journal-title":"Dermatoendocrinol"},{"key":"10.1016\/j.jaad.2012.11.002_bib61","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1097\/00005792-200209000-00002","article-title":"The TNF receptor-associated periodic syndrome (TRAPS): emerging concepts of an autoinflammatory disorder","volume":"81","author":"Hull","year":"2002","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jaad.2012.11.002_bib62","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1001\/archderm.136.12.1487","article-title":"Tumor necrosis factor receptor-associated periodic syndrome: a novel syndrome with cutaneous manifestations","volume":"136","author":"Toro","year":"2000","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2012.11.002_bib63","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0092-8674(00)80721-7","article-title":"Germline mutations in the extracellular domains of the 55 kDa TNF receptor, TNFR1, define a family of dominantly inherited autoinflammatory syndromes","volume":"97","author":"McDermott","year":"1999","journal-title":"Cell"},{"key":"10.1016\/j.jaad.2012.11.002_bib64","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1186\/ar2197","article-title":"Falling into TRAPS\u2013receptor misfolding in the TNF receptor 1-associated periodic fever syndrome","volume":"9","author":"Kimberley","year":"2007","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jaad.2012.11.002_bib65","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1002\/art.23475","article-title":"Persistent efficacy of anakinra in patients with tumor necrosis factor receptor-associated periodic syndrome","volume":"58","author":"Gattorno","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaad.2012.11.002_bib66","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1002\/art.30215","article-title":"Role of interleukin-6 in a patient with tumor necrosis factor receptor-associated periodic syndrome: assessment of outcomes following treatment with the anti-interleukin-6 receptor monoclonal antibody tocilizumab","volume":"63","author":"Vaitla","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaad.2012.11.002_bib67","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1007\/s00431-008-0685-2","article-title":"TNF receptor-associated periodic syndrome (TRAPS): description of a novel TNFRSF1A mutation and response to etanercept","volume":"167","author":"Jesus","year":"2008","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.jaad.2012.11.002_bib68","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1056\/NEJM200010053431412","article-title":"Treatment of the nephrotic syndrome with etanercept in patients with the tumor necrosis factor receptor-associated periodic syndrome","volume":"343","author":"Drewe","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2012.11.002_bib69","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1002\/art.33416","article-title":"Efficacy of etanercept in the tumor necrosis factor receptor-associated periodic syndrome (TRAPS)","volume":"64","author":"Bulua","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaad.2012.11.002_bib70","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/rheumatology\/keg070","volume":"42","author":"Drewe","year":"2003","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jaad.2012.11.002_bib71","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1002\/art.24294","article-title":"Proinflammatory action of the antiinflammatory drug infliximab in tumor necrosis factor receptor-associated periodic syndrome","volume":"60","author":"Nedjai","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaad.2012.11.002_bib72","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1001\/archderm.1994.01690010063008","article-title":"Cutaneous manifestations and histologic findings in the hyperimmunoglobulinemia D syndrome: international hyper IgD study group","volume":"130","author":"Drenth","year":"1994","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2012.11.002_bib73","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1097\/MD.0b013e318190cfb7","article-title":"Long-term follow-up, clinical features, and quality of life in a series of 103 patients with hyperimmunoglobulinemia D syndrome","volume":"87","author":"van der Hilst","year":"2008","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jaad.2012.11.002_bib74","doi-asserted-by":"crossref","first-page":"e152","DOI":"10.1542\/peds.2010-3639","article-title":"Mevalonate kinase deficiency: a survey of 50 patients","volume":"128","author":"Bader-Meunier","year":"2011","journal-title":"Pediatrics"},{"key":"10.1016\/j.jaad.2012.11.002_bib75","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1001\/archderm.1990.01670360085015","article-title":"IgD immune complex vasculitis in a patient with hyperimmunoglobulinemia D and periodic fever","volume":"126","author":"Boom","year":"1990","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2012.11.002_bib76","unstructured":"Milhavet F, Touitou I. Infevers: an online database for autoinflammatory mutations. Copyright 2001-2013. Available at http:\/\/fmf.igh.cnrs.fr\/ISSAID\/infevers\/. Accessed April 5, 2012."},{"key":"10.1016\/j.jaad.2012.11.002_bib77","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1684\/ecn.2009.0163","article-title":"Specific increase in caspase-1 activity and secretion of IL-1 family cytokines: a putative link between mevalonate kinase deficiency and inflammation","volume":"20","author":"Normand","year":"2009","journal-title":"Eur Cytokine Netw"},{"key":"10.1016\/j.jaad.2012.11.002_bib78","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1038\/ejhg.2010.9","article-title":"The inhibition of mevalonate pathway induces up-regulation of NALP3 expression: new insight in the pathogenesis of mevalonate kinase deficiency","volume":"18","author":"Pontillo","year":"2010","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.jaad.2012.11.002_bib79","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1038\/ni.1748","article-title":"Immunoglobulin D enhances immune surveillance by activating antimicrobial, proinflammatory and B cell-stimulating programs in basophils","volume":"10","author":"Chen","year":"2009","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jaad.2012.11.002_bib80","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1056\/NEJMra010200","article-title":"Hereditary periodic fever","volume":"345","author":"Drenth","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2012.11.002_bib81","doi-asserted-by":"crossref","first-page":"3586","DOI":"10.1182\/blood.V85.12.3586.bloodjournal85123586","article-title":"Cytokine activation during attacks of the hyperimmunoglobulinemia D and periodic fever syndrome","volume":"85","author":"Drenth","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.jaad.2012.11.002_bib82","doi-asserted-by":"crossref","first-page":"e82","DOI":"10.1016\/j.ejim.2008.04.009","article-title":"A patient with hyper-IgD syndrome responding to simvastatin treatment","volume":"19","author":"Attout","year":"2008","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.jaad.2012.11.002_bib83","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1007\/s10067-006-0501-1","article-title":"A patient with hyper-IgD syndrome responding to anti-TNF treatment","volume":"26","author":"Demirkaya","year":"2007","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.jaad.2012.11.002_bib84","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.clpt.2004.01.012","article-title":"Simvastatin treatment for inflammatory attacks of the hyperimmunoglobulinemia D and periodic fever syndrome","volume":"75","author":"Simon","year":"2004","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jaad.2012.11.002_bib85","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1007\/s10067-008-0911-3","article-title":"Hyperimmunoglobulinemia D and periodic fever syndrome; treatment with etanercept and follow-up","volume":"27","author":"Topaloglu","year":"2008","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.jaad.2012.11.002_bib86","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1651-2227.2010.01974.x","article-title":"Hyperimmunoglobulinemia D and periodic fever syndrome in children: review on therapy with biological drugs and case report","volume":"100","author":"Korppi","year":"2011","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.jaad.2012.11.002_bib87","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00296-006-0164-x","article-title":"Treatment with anakinra in the hyperimmunoglobulinemia D\/periodic fever syndrome","volume":"27","author":"Rigante","year":"2006","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.jaad.2012.11.002_bib88","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1136\/ard.2011.149922","article-title":"On-demand anakinra treatment is effective in mevalonate kinase deficiency","volume":"70","author":"Bodar","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaad.2012.11.002_bib89","first-page":"260","article-title":"Effect of etanercept and anakinra on inflammatory attacks in the hyper-IgD syndrome: introducing a vaccination provocation model","volume":"63","author":"Bodar","year":"2005","journal-title":"Neth J Med"},{"key":"10.1016\/j.jaad.2012.11.002_bib90","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1097\/GIM.0b013e3182060456","article-title":"Familial Mediterranean fever\u2013a review","volume":"13","author":"Shohat","year":"2011","journal-title":"Genet Med"},{"key":"10.1016\/j.jaad.2012.11.002_bib91","first-page":"69","article-title":"Protracted febrile myalgia syndrome with Henoch-Sch\u00f6nlein purpura: an atypical presentation of familial Mediterranean fever","volume":"36","author":"Cabral","year":"2011","journal-title":"Acta Reumatol Port"},{"key":"10.1016\/j.jaad.2012.11.002_bib92","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/j.1346-8138.2010.01003.x","article-title":"Erysipelas-like erythema with familial Mediterranean fever","volume":"38","author":"Aydin","year":"2011","journal-title":"J Dermatol"},{"key":"10.1016\/j.jaad.2012.11.002_bib93","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1001\/archderm.1976.01630270040009","article-title":"Cutaneous manifestations of familial Mediterranean fever","volume":"112","author":"Azizi","year":"1976","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2012.11.002_bib94","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1001\/archderm.143.8.1080","article-title":"Late-onset familial Mediterranean fever: an atypical presentation of dermatologic interest","volume":"143","author":"Satta","year":"2007","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2012.11.002_bib95","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1007\/s10067-006-0323-1","article-title":"Vasculitis in siblings with familial Mediterranean fever: a report of three cases and review of the literature","volume":"26","author":"Balbir-Gurman","year":"2007","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.jaad.2012.11.002_bib96","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/s00467-004-1440-1","article-title":"Variable expression of vasculitis in siblings with familial Mediterranean fever","volume":"19","author":"Lange-Sperandio","year":"2004","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.jaad.2012.11.002_bib97","first-page":"887","article-title":"Recurrent pleurisy as sole manifestation of familial Mediterranean fever","volume":"152","author":"ten Oever","year":"2008","journal-title":"Ned Tijdschr Geneeskd"},{"key":"10.1016\/j.jaad.2012.11.002_bib98","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1159\/000272314","article-title":"Isolated recurrent pleuritis revealing familial Mediterranean fever in adulthood","volume":"79","author":"Lega","year":"2010","journal-title":"Respiration"},{"key":"10.1016\/j.jaad.2012.11.002_bib99","first-page":"CS139","article-title":"Recurrent pericarditis as the initial manifestation of familial Mediterranean fever","volume":"14","author":"Okutur","year":"2008","journal-title":"Med Sci Monit"},{"key":"10.1016\/j.jaad.2012.11.002_bib100","doi-asserted-by":"crossref","first-page":"410","DOI":"10.3109\/s10165-010-0288-4","article-title":"Protracted febrile myalgia syndrome in familial Mediterranean fever","volume":"20","author":"Senel","year":"2010","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.jaad.2012.11.002_bib101","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/sj.ejhg.5200303","article-title":"Phenotype-genotype correlation in familial Mediterranean fever: evidence for an association between Met694Val and amyloidosis","volume":"7","author":"Shohat","year":"1999","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.jaad.2012.11.002_bib102","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/sj.ejhg.5200776","article-title":"The differential contribution of MEFV mutant alleles to the clinical profile of familial Mediterranean fever","volume":"10","author":"Gershoni-Baruch","year":"2002","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.jaad.2012.11.002_bib103","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1089\/gte.2008.0009","article-title":"Analysis of familial Mediterranean fever gene mutations in 202 patients with familial Mediterranean fever","volume":"12","author":"Solak","year":"2008","journal-title":"Genet Test"},{"key":"10.1016\/j.jaad.2012.11.002_bib104","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1080\/030097498440949","article-title":"Familial Mediterranean fever: from the clinical syndrome to the cloning of the pyrin gene","volume":"27","author":"Pras","year":"1998","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.jaad.2012.11.002_bib105","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1002\/art.22507","article-title":"Country as the primary risk factor for renal amyloidosis in familial Mediterranean fever","volume":"56","author":"Touitou","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaad.2012.11.002_bib106","first-page":"2620","article-title":"Intravenous colchicine for treatment of patients with familial Mediterranean fever unresponsive to oral colchicine","volume":"30","author":"Lidar","year":"2003","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jaad.2012.11.002_bib107","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1111\/j.1365-2362.2007.01868.x","article-title":"Anakinra in two adolescent female patients suffering from colchicine-resistant familial Mediterranean fever: effective but risky","volume":"37","author":"Gattringer","year":"2007","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.jaad.2012.11.002_bib108","doi-asserted-by":"crossref","first-page":"825","DOI":"10.7326\/0003-4819-146-11-200706050-00023","article-title":"Treatment of familial Mediterranean fever with anakinra","volume":"146","author":"Belkhir","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jaad.2012.11.002_bib109","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1136\/ard.2007.071498","article-title":"Effective treatment of a colchicine-resistant familial Mediterranean fever patient with anakinra","volume":"66","author":"Kuijk","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaad.2012.11.002_bib110","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.semarthrit.2010.11.003","article-title":"Interleukin-1 targeting drugs in familial Mediterranean fever: a case series and a review of the literature","volume":"41","author":"Meinzer","year":"2011","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.jaad.2012.11.002_bib111","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1093\/ndt\/gfn646","article-title":"Successful treatment of familial Mediterranean fever with anakinra and outcome after renal transplantation","volume":"24","author":"Moser","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.jaad.2012.11.002_bib112","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1007\/s00431-008-0875-y","article-title":"Sulfasalazine treatment in protracted familial Mediterranean fever arthritis","volume":"168","author":"Bakkaloglu","year":"2009","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.jaad.2012.11.002_bib113","first-page":"S43","article-title":"Successful treatment of familial Mediterranean fever attacks with thalidomide in a colchicine resistant patient","volume":"20","author":"Seyahi","year":"2002","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.jaad.2012.11.002_bib114","first-page":"S99","article-title":"Treatment options in colchicine resistant familial Mediterranean fever patients: thalidomide and etanercept as adjunctive agents","volume":"24","author":"Seyahi","year":"2006","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.jaad.2012.11.002_bib115","first-page":"435","article-title":"Etanercept in the treatment of arthritis in a patient with familial Mediterranean fever","volume":"24","author":"Sakallioglu","year":"2006","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.jaad.2012.11.002_bib116","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1097\/01.rhu.0000255772.25658.7c","article-title":"Familial Mediterranean fever successfully treated with etanercept","volume":"13","author":"Mor","year":"2007","journal-title":"J Clin Rheumatol"},{"key":"10.1016\/j.jaad.2012.11.002_bib117","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1056\/NEJMoa0807865","article-title":"An autoinflammatory disease with deficiency of the interleukin-1-receptor antagonist","volume":"360","author":"Aksentijevich","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2012.11.002_bib118","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.jaad.2009.04.046","article-title":"Chronic atypical neutrophilic dermatosis with lipodystrophy and elevated temperature (CANDLE) syndrome","volume":"62","author":"Torrelo","year":"2010","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2012.11.002_bib119","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1111\/j.1525-1470.2010.01163.x","article-title":"Chronic atypical neutrophilic dermatosis with lipodystrophy and elevated temperature syndrome: a case report","volume":"28","author":"Ramot","year":"2011","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.jaad.2012.11.002_bib120","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1002\/art.33368","article-title":"Mutations in proteasome subunit beta type 8 cause chronic atypical neutrophilic dermatosis with lipodystrophy and elevated temperature with evidence of genetic and phenotypic heterogeneity","volume":"64","author":"Liu","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaad.2012.11.002_bib121","doi-asserted-by":"crossref","first-page":"2937","DOI":"10.1210\/jc.2008-1019","article-title":"Approach to the human immunodeficiency virus-infected patient with lipodystrophy","volume":"93","author":"Brown","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jaad.2012.11.002_bib122","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1093\/jac\/dkn251","article-title":"HIV-associated lipodystrophy: a review of underlying mechanisms and therapeutic options","volume":"62","author":"Mallewa","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jaad.2012.11.002_bib123","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0950-3579(94)80022-7","article-title":"The SAPHO syndrome","volume":"8","author":"Kahn","year":"1994","journal-title":"Baillieres Clin Rheumatol"},{"key":"10.1016\/j.jaad.2012.11.002_bib124","doi-asserted-by":"crossref","first-page":"100","DOI":"10.2174\/1874325000903010100","article-title":"SAPHO syndrome diagnosis and treatment: report of five cases and review of the literature","volume":"3","author":"Matzaroglou","year":"2009","journal-title":"Open Orthop J"},{"key":"10.1016\/j.jaad.2012.11.002_bib125","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/BF00270522","article-title":"Monarthritis of the manubriosternal joint: a follow-up study","volume":"7","author":"Jurik","year":"1987","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.jaad.2012.11.002_bib126","first-page":"109","article-title":"Synovitis-acne-pustulosis hyperostosis-osteomyelitis syndrome (SAPHO): a new syndrome among the spondyloarthropathies?","volume":"6","author":"Benhamou","year":"1988","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.jaad.2012.11.002_bib127","first-page":"187","article-title":"Acne-pustulosis-hyperostosis-osteitis syndrome: results of a national survey, 85 cases","volume":"54","author":"Chamot","year":"1987","journal-title":"Rev Rhum Mal Osteoartic"},{"key":"10.1016\/j.jaad.2012.11.002_bib128","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1136\/ard.40.6.547","article-title":"Clinical features of 53 cases with pustulotic arthro-osteitis","volume":"40","author":"Sonozaki","year":"1981","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaad.2012.11.002_bib129","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/BF02054261","article-title":"Acne conglobata and arthritis: report of a case and review of the literature","volume":"5","author":"Ehrenfeld","year":"1986","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.jaad.2012.11.002_bib130","first-page":"1104","article-title":"Sternoclavicular pustulotic osteitis (SAPHO): 20-year interval between skin and bone lesions","volume":"18","author":"Kahn","year":"1991","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jaad.2012.11.002_bib131","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.autrev.2008.07.030","article-title":"SAPHO syndrome and infections","volume":"8","author":"Govoni","year":"2009","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.jaad.2012.11.002_bib132","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1093\/rheumatology\/keq074","article-title":"Dysregulation of P2X7 receptor-inflammasome axis in SAPHO syndrome: successful treatment with anakinra","volume":"49","author":"Colina","year":"2010","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jaad.2012.11.002_bib133","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1136\/annrheumdis-2011-200743","article-title":"Anakinra treatment of SAPHO syndrome: short-term results of an open study","volume":"71","author":"Wendling","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaad.2012.11.002_bib134","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.3899\/jrheum.091086","article-title":"Tumor necrosis factor-alpha blockers in SAPHO syndrome","volume":"37","author":"Ben Abdelghani","year":"2010","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jaad.2012.11.002_bib135","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0022-3476(78)80501-0","article-title":"Chronic recurrent multifocal osteomyelitis and pustulosis palmoplantaris","volume":"93","author":"Bjorksten","year":"1978","journal-title":"J Pediatr"},{"key":"10.1016\/j.jaad.2012.11.002_bib136","first-page":"611","article-title":"Pustulotic arthroosteitis","volume":"12","author":"Patterson","year":"1985","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jaad.2012.11.002_bib137","first-page":"1410","article-title":"Osteite rhumatismale aseptique associee la pustulose palmoplantaire. Interet de la colchicine","volume":"17","author":"Berbis","year":"1988","journal-title":"Rev Rhum Mal Osteoartic"},{"key":"10.1016\/j.jaad.2012.11.002_bib138","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1136\/ard.47.10.809","article-title":"Palmoplantar pustulosis and sternocostoclavicular arthro-osteitis","volume":"47","author":"Edlund","year":"1988","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaad.2012.11.002_bib139","first-page":"344","article-title":"Acne fulminans with a lytic bone lesion responsive to dapsone","volume":"9","author":"Siegel","year":"1982","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jaad.2012.11.002_bib140","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1089\/jir.1995.15.837","article-title":"Effective treatment with interferon-alpha in chronic recurrent multifocal osteomyelitis","volume":"15","author":"Andersson","year":"1995","journal-title":"J Interferon Cytokine Res"},{"key":"10.1016\/j.jaad.2012.11.002_bib141","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.3950\/jibiinkoka.97.1621","article-title":"Efficacy of tonsillectomy for improving skin lesions of pustulosis palmaris et plantaris\u2013evaluation of 289 cases at the Department of Otolaryngology of Sapporo Medical University","volume":"97","author":"Tsubota","year":"1994","journal-title":"Nihon Jibiinkoka Gakkai Kaiho"},{"key":"10.1016\/j.jaad.2012.11.002_bib142","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1111\/j.1346-8138.1993.tb01380.x","article-title":"Serum levels of interleukin 6 in patients with pustulosis palmaris et plantaris","volume":"20","author":"Nakamura","year":"1993","journal-title":"J Dermatol"},{"key":"10.1016\/j.jaad.2012.11.002_bib143","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.autrev.2011.01.003","article-title":"Schnitzler syndrome, an autoimmune-autoinflammatory syndrome: report of two new cases and review of the literature","volume":"10","author":"Tinazzi","year":"2011","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.jaad.2012.11.002_bib144","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.semarthrit.2007.04.001","article-title":"Schnitzler syndrome: beyond the case reports; review and follow-up of 94 patients with an emphasis on prognosis and treatment","volume":"37","author":"de Koning","year":"2007","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.jaad.2012.11.002_bib145","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/S0190-9622(89)70023-2","article-title":"Chronic urticaria and macroglobulinemia (Schnitzler's syndrome): report of two cases","volume":"20","author":"Janier","year":"1989","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2012.11.002_bib146","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/0091-6749(91)90132-8","article-title":"Schnitzler's syndrome: a broader clinical spectrum","volume":"87","author":"Berdy","year":"1991","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaad.2012.11.002_bib147","first-page":"366","article-title":"Severe thrombophilia with antiphospholipid syndrome and hyperhomocysteinemia in a patient with Schnitzler's syndrome","volume":"21","author":"Famularo","year":"2003","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.jaad.2012.11.002_bib148","first-page":"660","article-title":"Impairment of renal function in Schnitzler's syndrome","volume":"19","author":"Westhoff","year":"2006","journal-title":"J Nephrol"},{"key":"10.1016\/j.jaad.2012.11.002_bib149","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1080\/10428190210181","article-title":"Malignant evolution of Schnitzler's syndrome\u2013chronic urticaria and IgM monoclonal gammopathy: report of a new case and review of the literature","volume":"43","author":"Lim","year":"2002","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.jaad.2012.11.002_bib150","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1177\/014107687907201115","article-title":"Urticaria in Waldenstrom's macroglobulinemia","volume":"72","author":"Cream","year":"1979","journal-title":"J R Soc Med"},{"key":"10.1016\/j.jaad.2012.11.002_bib151","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/S0190-9622(89)80127-6","article-title":"Urticarial dermatosis associated with Waldenstrom's macroglobulinemia","volume":"20","author":"Pujol","year":"1989","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2012.11.002_bib152","doi-asserted-by":"crossref","first-page":"413","DOI":"10.2340\/0001555576413413","article-title":"Schnitzler's syndrome (urticaria and macroglobulinemia): evolution to Waldenstrom's disease is not uncommon","volume":"76","author":"Machet","year":"1996","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jaad.2012.11.002_bib153","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1046\/j.1440-0960.1999.00361.x","article-title":"Schnitzler's syndrome: report of a case with progression to Waldenstrom's macroglobulinemia","volume":"40","author":"Welsh","year":"1999","journal-title":"Australas J Dermatol"},{"key":"10.1016\/j.jaad.2012.11.002_bib154","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1684\/ecn.2009.0164","article-title":"Free circulating interleukin-18 is increased in Schnitzler syndrome: a new autoinflammatory disease?","volume":"20","author":"Migliorini","year":"2009","journal-title":"Eur Cytokine Netw"},{"key":"10.1016\/j.jaad.2012.11.002_bib155","doi-asserted-by":"crossref","first-page":"e123","DOI":"10.1111\/j.1365-2230.2009.03746.x","article-title":"Schnitzler's syndrome with prominent neutrophil infiltration misdiagnosed as Sweet's syndrome: a typical example of urticarial neutrophilic dermatosis","volume":"35","author":"Asahina","year":"2010","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jaad.2012.11.002_bib156","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1093\/rheumatology\/kep222","article-title":"Dysfunctional inflammasome in Schnitzler's syndrome","volume":"48","author":"Pizzirani","year":"2009","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jaad.2012.11.002_bib157","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1177\/039463201002300226","article-title":"Successful treatment of Schnitzler's syndrome with anakinra after failure of rituximab trial","volume":"23","author":"Cascavilla","year":"2010","journal-title":"Int J Immunopathol Pharmacol"},{"key":"10.1016\/j.jaad.2012.11.002_bib158","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/s10067-010-1375-9","article-title":"Dramatic response to IL1-RA treatment in longstanding multidrug resistant Schnitzler's syndrome: a case report and literature review","volume":"29","author":"Besada","year":"2010","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.jaad.2012.11.002_bib159","doi-asserted-by":"crossref","first-page":"287","DOI":"10.2340\/00015555-0404","article-title":"Efficacy of interleukin 1 receptor antagonist (anakinra) on a refractory case of Schnitzler's syndrome","volume":"88","author":"Kluger","year":"2008","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jaad.2012.11.002_bib160","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.jbspin.2006.11.018","article-title":"Effectiveness of anti-IL1 in Schnitzler's syndrome","volume":"74","author":"Klemmer","year":"2007","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.jaad.2012.11.002_bib161","first-page":"1536","article-title":"Efficacy of psoralen-UV-A therapy in 3 cases of Schnitzler syndrome","volume":"137","author":"Cianchini","year":"2001","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2012.11.002_bib162","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/j.jaci.2011.10.031","article-title":"Complete remission in 3 of 3 anti-IL-6-treated patients with Schnitzler syndrome","volume":"129","author":"Krause","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaad.2012.11.002_bib163","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1002\/art.21101","article-title":"Successful treatment of refractory Schnitzler syndrome with anakinra: comment on the article by Hawkins et\u00a0al","volume":"52","author":"Martinez-Taboada","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaad.2012.11.002_bib164","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.jbspin.2010.02.016","article-title":"Schnitzler's syndrome improvement after anti-TNF-alpha therapy","volume":"77","author":"Aikawa","year":"2010","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.jaad.2012.11.002_bib165","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/00005792-200101000-00004","article-title":"The Schnitzler syndrome: four new cases and review of the literature","volume":"80","author":"Lipsker","year":"2001","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jaad.2012.11.002_bib166","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0248-8663(00)80049-1","article-title":"Schnitzler syndrome: a rare cause of systemic urticaria","volume":"21","author":"Germain","year":"2000","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.jaad.2012.11.002_bib167","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1046\/j.1468-3083.2002.00459.x","article-title":"Schnitzler's syndrome with monoclonal IgG kappa gammopathy: good response to cyclosporin","volume":"16","author":"Pascual-Lopez","year":"2002","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2012.11.002_bib168","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1046\/j.1365-2133.2003.05209_9.x","article-title":"Schnitzler's syndrome: successful treatment of two patients using thalidomide","volume":"148","author":"Worm","year":"2003","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2012.11.002_bib169","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1136\/ard.2005.045245","article-title":"Beneficial response to anakinra and thalidomide in Schnitzler's syndrome","volume":"65","author":"de Koning","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaad.2012.11.002_bib170","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1159\/000063139","article-title":"Report of a case of Schnitzler's syndrome treated successfully with interferon alpha 2b","volume":"205","author":"Schartz","year":"2002","journal-title":"Dermatology"},{"key":"10.1016\/j.jaad.2012.11.002_bib171","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1159\/000063142","article-title":"Successful treatment of Schnitzler's syndrome with interferon alfa-2b","volume":"205","author":"Kuenzli","year":"2002","journal-title":"Dermatology"},{"key":"10.1016\/j.jaad.2012.11.002_bib172","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3109\/s10165-003-0259-0","article-title":"Inflammatory cytokines and systemic-onset juvenile idiopathic arthritis","volume":"14","author":"Yokota","year":"2004","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.jaad.2012.11.002_bib173","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1093\/rheumatology\/kem271","article-title":"New insights in systemic juvenile idiopathic arthritis\u2013from pathophysiology to treatment","volume":"47","author":"Frosch","year":"2008","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jaad.2012.11.002_bib174","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1007\/s10067-005-0138-5","article-title":"A multicenter study of patients with adult-onset Still's disease compared with systemic juvenile idiopathic arthritis","volume":"25","author":"Pay","year":"2006","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.jaad.2012.11.002_bib175","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1007\/s12098-008-0046-1","article-title":"Systemic onset juvenile idiopathic arthritis\u2013its unusual presentation","volume":"75","author":"Ghosh","year":"2008","journal-title":"Indian J Pediatr"},{"key":"10.1016\/j.jaad.2012.11.002_bib176","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.3899\/jrheum.100266","article-title":"Malar rash in systemic juvenile idiopathic arthritis","volume":"37","author":"Muskardin","year":"2010","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jaad.2012.11.002_bib177","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/j.0906-6705.2005.00271.x","article-title":"Early activation of cutaneous vessels and epithelial cells is characteristic of acute systemic onset juvenile idiopathic arthritis","volume":"14","author":"Frosch","year":"2005","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.jaad.2012.11.002_bib178","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1136\/ard.2007.076034","article-title":"Interleukin-1 receptor antagonist (anakinra) treatment in patients with systemic-onset juvenile idiopathic arthritis or adult onset Still disease: preliminary experience in France","volume":"67","author":"Lequerre","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaad.2012.11.002_bib179","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1084\/jem.20050473","article-title":"Role of interleukin-1 (IL-1) in the pathogenesis of systemic onset juvenile idiopathic arthritis and clinical response to IL-1 blockade","volume":"201","author":"Pascual","year":"2005","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaad.2012.11.002_bib180","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1136\/ard.2010.134254","article-title":"A multicenter, randomized, double-blind, placebo-controlled trial with the interleukin-1 receptor antagonist anakinra in patients with systemic-onset juvenile idiopathic arthritis (ANAJIS trial)","volume":"70","author":"Quartier","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaad.2012.11.002_bib181","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.jaci.2005.02.034","article-title":"Association of NOD1 polymorphisms with atopic eczema and related phenotypes","volume":"116","author":"Weidinger","year":"2005","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaad.2012.11.002_bib182","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1067\/mai.2003.1336","article-title":"Association between polymorphisms in caspase recruitment domain containing protein 15 and allergy in two German populations","volume":"111","author":"Kabesch","year":"2003","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaad.2012.11.002_bib183","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/j.1600-0625.2007.00589.x","article-title":"Polymorphisms in NACHT-LRR (NLR) genes in atopic dermatitis","volume":"16","author":"Macaluso","year":"2007","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.jaad.2012.11.002_bib184","doi-asserted-by":"crossref","first-page":"583","DOI":"10.3109\/08916930903540432","article-title":"Two SNPs in NLRP3 gene are involved in the predisposition to type-1 diabetes and celiac disease in a pediatric population from northeast Brazil","volume":"43","author":"Pontillo","year":"2010","journal-title":"Autoimmunity"},{"key":"10.1016\/j.jaad.2012.11.002_bib185","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/j.jaci.2010.12.006","article-title":"Mite allergen is a danger signal for the skin via activation of inflammasome in keratinocytes","volume":"127","author":"Dai","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaad.2012.11.002_bib186","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1038\/sj.jid.5700819","article-title":"Activation of the IL-1beta-processing inflammasome is involved in contact hypersensitivity","volume":"127","author":"Watanabe","year":"2007","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2012.11.002_bib187","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1111\/j.0022-202X.2004.23435.x","article-title":"The development and characterization of an in\u00a0vitro model of psoriasis","volume":"123","author":"Barker","year":"2004","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2012.11.002_bib188","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.1038\/jid.2010.196","article-title":"A comprehensive analysis of pattern recognition receptors in normal and inflamed human epidermis: up-regulation of dectin-1 in psoriasis","volume":"130","author":"de Koning","year":"2010","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2012.11.002_bib189","doi-asserted-by":"crossref","unstructured":"Garcia-Rodriguez S, Arias-Santiago S, Perandres-Lopez R, Castellote L, Zumaquero E, Navarro P, et al. Increased gene expression of Toll-like receptor 4 on peripheral blood mononuclear cells in patients with psoriasis. J Eur Acad Dermatol Venereol doi: 10.1111\/j.1468-3083.2011.04372.x. Published online December 6, 2011.","DOI":"10.1111\/j.1468-3083.2011.04372.x"},{"key":"10.1016\/j.jaad.2012.11.002_bib190","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s004030050319","article-title":"IL-1 and IL-1 receptor antagonist regulation during keratinocyte cell cycle and differentiation in normal and psoriatic epidermis","volume":"290","author":"Hammerberg","year":"1998","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.jaad.2012.11.002_bib191","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1111\/j.1365-2133.2010.09990.x","article-title":"Elevation of serum epidermal growth factor and interleukin 1 receptor antagonist in active psoriasis vulgaris","volume":"163","author":"Anderson","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2012.11.002_bib192","doi-asserted-by":"crossref","first-page":"2955","DOI":"10.4049\/jimmunol.158.6.2955","article-title":"The IL-1 system in psoriatic skin: IL-1 antagonist sphere of influence in lesional psoriatic epidermis","volume":"158","author":"Debets","year":"1997","journal-title":"J Immunol"},{"key":"10.1016\/j.jaad.2012.11.002_bib193","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/j.1365-2133.1992.tb00446.x","article-title":"Distribution of interleukin 1 receptor antagonist protein (IRAP), interleukin 1 receptor, and interleukin 1 alpha in normal and psoriatic skin: decreased expression of IRAP in psoriatic lesional epidermis","volume":"127","author":"Kristensen","year":"1992","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2012.11.002_bib194","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1007\/s10067-010-1504-5","article-title":"An open-label pilot study of the efficacy and safety of anakinra in patients with psoriatic arthritis refractory to or intolerant of methotrexate (MTX)","volume":"29","author":"Jung","year":"2010","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.jaad.2012.11.002_bib195","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1056\/NEJMoa1013068","article-title":"Interleukin-36-receptor antagonist deficiency and generalized pustular psoriasis","volume":"365","author":"Marrakchi","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2012.11.002_bib196","doi-asserted-by":"crossref","first-page":"66","DOI":"10.7326\/0003-4819-153-1-201007060-00030","article-title":"Successful treatment of generalized pustular psoriasis with the interleukin-1-receptor antagonist anakinra: lack of correlation with IL1RN mutations","volume":"153","author":"Viguier","year":"2010","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jaad.2012.11.002_bib197","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1001\/archdermatol.2011.2473","article-title":"Acitretin- and tumor necrosis factor inhibitor-resistant acrodermatitis continua of Hallopeau responsive to the interleukin 1 receptor antagonist anakinra","volume":"148","author":"Lutz","year":"2012","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2012.11.002_bib198","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1093\/hmg\/11.8.961","article-title":"Mutations in CD2BP1 disrupt binding to PTP PEST and are responsible for PAPA syndrome, an autoinflammatory disorder","volume":"11","author":"Wise","year":"2002","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.jaad.2012.11.002_bib199","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.molcel.2007.08.029","article-title":"Pyrin activates the ASC pyroptosome in response to engagement by autoinflammatory PSTPIP1 mutants","volume":"28","author":"Yu","year":"2007","journal-title":"Mol Cell"},{"key":"10.1016\/j.jaad.2012.11.002_bib200","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1111\/j.1365-2230.2011.04137.x","article-title":"Mutations in the PSTPIP1 gene and aberrant splicing variants in patients with pyoderma gangrenosum","volume":"36","author":"Nesterovitch","year":"2011","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jaad.2012.11.002_bib201","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/35079114","article-title":"A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease","volume":"411","author":"Ogura","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.jaad.2012.11.002_bib202","doi-asserted-by":"crossref","first-page":"8869","DOI":"10.1074\/jbc.C200651200","article-title":"Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection","volume":"278","author":"Girardin","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jaad.2012.11.002_bib203","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1001\/archdermatol.2010.328","article-title":"Hidradenitis suppurativa and concomitant pyoderma gangrenosum: a case series and literature review","volume":"146","author":"Hsiao","year":"2010","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2012.11.002_bib204","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1186\/1752-1947-2-221","article-title":"Sweet's syndrome in a patient with Crohn's disease: a case report","volume":"2","author":"Mustafa","year":"2008","journal-title":"J Med Case Rep"},{"key":"10.1016\/j.jaad.2012.11.002_bib205","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1136\/bmj.297.6662.1513-a","article-title":"Sweet's syndrome in Crohn's disease","volume":"297","author":"Kemmett","year":"1988","journal-title":"BMJ"},{"key":"10.1016\/j.jaad.2012.11.002_bib206","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1136\/ard.2006.068254","article-title":"Efficacy of anakinra, an IL1 receptor antagonist, in refractory Sweet syndrome","volume":"67","author":"Delluc","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaad.2012.11.002_bib207","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1159\/000326112","article-title":"Efficacy of anti-interleukin-1 receptor antagonist anakinra (Kineret\u00ae) in a case of refractory Sweet's syndrome","volume":"222","author":"Kluger","year":"2011","journal-title":"Dermatology"},{"key":"10.1016\/j.jaad.2012.11.002_bib208","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1159\/000319851","article-title":"Association study of tumor necrosis factor receptor type 2 M196R and toll-like receptor 2 Arg753Gln polymorphisms with acne vulgaris in a Chinese Han ethnic group","volume":"221","author":"Tian","year":"2010","journal-title":"Dermatology"},{"key":"10.1016\/j.jaad.2012.11.002_bib209","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1111\/j.1399-0039.2010.01530.x","article-title":"Interleukin-1A +4845(G> T) polymorphism is a factor predisposing to acne vulgaris","volume":"76","author":"Szabo","year":"2010","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.jaad.2012.11.002_bib210","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/jid.2008.237","article-title":"Glucocorticoids enhance Toll-like receptor 2 expression in human keratinocytes stimulated with Propionibacterium acnes or proinflammatory cytokines","volume":"129","author":"Shibata","year":"2009","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2012.11.002_bib211","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1111\/j.1600-0625.2008.00753.x","article-title":"Granulomatous rosacea and Crohn's disease in a patient homozygous for the Crohn-associated NOD2\/CARD15 polymorphism R702W","volume":"17","author":"van Steensel","year":"2008","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.jaad.2012.11.002_bib212","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1111\/j.1365-4632.2007.03293.x","article-title":"Is there a role for infliximab in the current therapy of hidradenitis suppurativa? A report of three treated cases","volume":"46","author":"Moschella","year":"2007","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2012.11.002_bib213","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.jaad.2010.12.025","article-title":"Pyoderma gangrenosum, acne, and suppurative hidradenitis (PASH)\u2013a new autoinflammatory syndrome distinct from PAPA syndrome","volume":"66","author":"Braun-Falco","year":"2012","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2012.11.002_bib214","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1002\/1098-1004(200009)16:3<271::AID-HUMU16>3.0.CO;2-A","article-title":"MEFV mutations in Beh\u00e7et\u2019s disease","volume":"16","author":"Touitou","year":"2000","journal-title":"Hum Mutat"},{"key":"10.1016\/j.jaad.2012.11.002_bib215","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/sj.ejhg.5200608","article-title":"A single mutated MEFV allele in Israeli patients suffering from familial Mediterranean fever and Beh\u00e7et\u2019s disease (FMF-BD)","volume":"9","author":"Livneh","year":"2001","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.jaad.2012.11.002_bib216","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1002\/art.20873","article-title":"Association of the R92Q TNFRSF1A mutation and extracranial deep vein thrombosis in patients with Beh\u00e7et\u2019s disease","volume":"52","author":"Amoura","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaad.2012.11.002_bib217","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1136\/ard.2006.068841","article-title":"Autoinflammatory gene mutations in Beh\u00e7et's disease","volume":"66","author":"Kone-Paut","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaad.2012.11.002_bib218","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1046\/j.0022-202x.2001.01676.x","article-title":"Interleukin-1 receptor antagonist allele 2 and familial alopecia areata","volume":"118","author":"Barahmani","year":"2002","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2012.11.002_bib219","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1046\/j.1365-2370.2002.00271.x","article-title":"Genetic analysis of the interleukin-1 receptor antagonist and its homologue IL-1L1 in alopecia areata: strong severity association and possible gene interaction","volume":"29","author":"Tazi-Ahnini","year":"2002","journal-title":"Eur J Immunogenet"},{"key":"10.1016\/j.jaad.2012.11.002_bib220","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1056\/NEJMoa061592","article-title":"NALP1 in vitiligo-associated multiple autoimmune disease","volume":"356","author":"Jin","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2012.11.002_bib221","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1159\/000112932","article-title":"Vitiligo improvement in a patient with ankylosing spondylitis treated with infliximab","volume":"216","author":"Simon","year":"2008","journal-title":"Dermatology"},{"key":"10.1016\/j.jaad.2012.11.002_bib222","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1159\/000102044","article-title":"Etanercept in the treatment of vitiligo","volume":"215","author":"Rigopoulos","year":"2007","journal-title":"Dermatology"},{"key":"10.1016\/j.jaad.2012.11.002_bib223","first-page":"303","article-title":"Circulating levels of tumor necrosis factor soluble receptors in systemic lupus erythematosus are significantly higher than in other rheumatic diseases and correlate with disease activity","volume":"24","author":"Gabay","year":"1997","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jaad.2012.11.002_bib224","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1191\/096120399678847560","article-title":"Synergetic effect between interleukin-1 receptor antagonist allele (IL1RN*2) and MHC class II (DR17, DQ2) in determining susceptibility to systemic lupus erythematosus","volume":"8","author":"Tjernstrom","year":"1999","journal-title":"Lupus"},{"key":"10.1016\/j.jaad.2012.11.002_bib225","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1136\/ard.2003.007336","article-title":"Systemic lupus erythematosus and genetic\u00a0variation in the interleukin 1 gene cluster: a population-based study in the southeastern United States","volume":"63","author":"Parks","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaad.2012.11.002_bib226","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1111\/j.1399-0039.2006.00704.x","article-title":"The different expression patterns of interleukin-1 receptor antagonist in systemic lupus erythematosus","volume":"68","author":"Tsai","year":"2006","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.jaad.2012.11.002_bib227","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/j.humimm.2010.06.004","article-title":"Measurement of interleukin-1 receptor antagonist in patients with systemic lupus erythematosus could predict renal manifestation of the disease","volume":"71","author":"Brugos","year":"2010","journal-title":"Hum Immunol"},{"key":"10.1016\/j.jaad.2012.11.002_bib228","doi-asserted-by":"crossref","first-page":"271","DOI":"10.3109\/08916934.2011.637532","article-title":"Polymorphisms in inflammasome genes are involved in the predisposition to systemic lupus erythematosus","volume":"45","author":"Pontillo","year":"2012","journal-title":"Autoimmunity"},{"key":"10.1016\/j.jaad.2012.11.002_bib229","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1191\/0961203304lu1047cr","article-title":"IL-1RA in refractory systemic lupus erythematosus","volume":"13","author":"Moosig","year":"2004","journal-title":"Lupus"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962212011942?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962212011942?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:28:01Z","timestamp":1759271281000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962212011942"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5]]},"references-count":229,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,5]]}},"alternative-id":["S0190962212011942"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2012.11.002","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2013,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Autoinflammation: From monogenic syndromes to common skin diseases","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2012.11.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}